Ardsley Advisory Partners’s Exact Sciences EXAS Stock Holding History

Ardsley Advisory Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-60,000	Closed	-$4.14M	–	153
2024 Q1	$4.14M	Buy	+60,000	New	+$3.8M	0.6%	51
2017 Q3	–	Sell	-7,500	Closed	-$265K	–	141
2017 Q2	$265K	Sell	7,500 -225,000	-97%	-$6.94M	0.04%	119
2017 Q1	$5.49M	Sell	232,500 -197,500	-46%	-$3.91M	0.85%	41
2016 Q4	$5.75M	Buy	+430,000	New	+$6.94M	0.95%	38
2016 Q1	–	Sell	-20,000	Closed	-$185K	–	160
2015 Q4	$185K	Buy	+20,000	New	+$186K	0.02%	133
2014 Q1	–	Sell	-20,000	Closed	-$235K	–	243
2013 Q4	$235K	Buy	+20,000	New	+$229K	0.03%	137

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Ardsley Advisory Partners's EXAS Position: Q2 2024 in Review

Ardsley Advisory Partners sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 60,000 shares — an estimated $4.14M sold.

Ardsley Advisory Partners first reported a position in EXAS in Q4 2013 and held it in 6 quarters. The position peaked at $5.75M in Q4 2016. 543 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

Ardsley Advisory Partners reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
Ardsley Advisory Partners sold 60,000 Exact Sciences shares in Q2 2024, an estimated $4.14M.
Ardsley Advisory Partners first reported a position in Exact Sciences in Q4 2013 and held it in 6 quarters.
Ardsley Advisory Partners's Exact Sciences position peaked at $5.75M in Q4 2016.
543 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Ardsley Advisory Partners's 13F filing for Q2 2024, filed 14 Aug 2024.